3 results about "Protease resistant" patented technology

Studies indicate that protease resistance is least likely to develop when these agents are given in combination with two nucleosides. Protease inhibitors should always be administered at optimal therapeutic doses; suboptimal doses of these drugs merely promote the development of high-level protease resistance.